Review





Similar Products

mouse monoclonal anti human cd9  (Developmental Studies Hybridoma Bank)
94
Developmental Studies Hybridoma Bank mouse monoclonal anti human cd9
Mouse Monoclonal Anti Human Cd9, supplied by Developmental Studies Hybridoma Bank, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse monoclonal anti human cd9/product/Developmental Studies Hybridoma Bank
Average 94 stars, based on 1 article reviews
mouse monoclonal anti human cd9 - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier
tetraspanins nupage dithiothreitol reducing agent  (Thermo Fisher)
98
Thermo Fisher tetraspanins nupage dithiothreitol reducing agent
Tetraspanins Nupage Dithiothreitol Reducing Agent, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/tetraspanins nupage dithiothreitol reducing agent/product/Thermo Fisher
Average 98 stars, based on 1 article reviews
tetraspanins nupage dithiothreitol reducing agent - by Bioz Stars, 2026-03
98/100 stars
  Buy from Supplier
tetraspanins cd9 apc  (Miltenyi Biotec)
94
Miltenyi Biotec tetraspanins cd9 apc
Lentiviral transduction to generate WT-, PanKO-, CD9KO-, CD63KO-, and CD81KO-cells expressing TlucCD9-Cerulean. A. Schematic workflow of generating engineered Tluc-EVs by introducing TlucCD9-Cerulean lentiviruses (created with BioRender.com ). B. The percentage of Cerulean positive cells. C. The mean fluorescence intensity (MFI) of Cerulean positive cells. D. Flow cytometry plot for the cells after staining with APC-conjugated <t>CD9/CD63/CD81</t> tetraspanin antibodies. E. Fold increase in engineered Tluc-CD9 EVs in PanKO-, CD9KO, CD63KO-, and CD81KO-cells over WT cells (Data are normalized to the RLU of EVs from WT cells). F. Fold increase of engineered Tluc-CD9EVs over PanKO-, CD9KO, CD63KO-, and CD81KO-cells (Data are normalized to the RLU of EVs from WT cells and compared across KO groups). G. Heatmap of tetraspanins in EVs. H. Interaction network of CD9 with the tetraspanins retrieved from STRING. The data are presented as means (±SD, n = 3-5). One-way ANOVA was used to show significance and was illustrated as follows: **** p < 0.0001.
Tetraspanins Cd9 Apc, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/tetraspanins cd9 apc/product/Miltenyi Biotec
Average 94 stars, based on 1 article reviews
tetraspanins cd9 apc - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier
extracellular loop  (Sino Biological)
94
Sino Biological extracellular loop
Lentiviral transduction to generate WT-, PanKO-, CD9KO-, CD63KO-, and CD81KO-cells expressing TlucCD9-Cerulean. A. Schematic workflow of generating engineered Tluc-EVs by introducing TlucCD9-Cerulean lentiviruses (created with BioRender.com ). B. The percentage of Cerulean positive cells. C. The mean fluorescence intensity (MFI) of Cerulean positive cells. D. Flow cytometry plot for the cells after staining with APC-conjugated <t>CD9/CD63/CD81</t> tetraspanin antibodies. E. Fold increase in engineered Tluc-CD9 EVs in PanKO-, CD9KO, CD63KO-, and CD81KO-cells over WT cells (Data are normalized to the RLU of EVs from WT cells). F. Fold increase of engineered Tluc-CD9EVs over PanKO-, CD9KO, CD63KO-, and CD81KO-cells (Data are normalized to the RLU of EVs from WT cells and compared across KO groups). G. Heatmap of tetraspanins in EVs. H. Interaction network of CD9 with the tetraspanins retrieved from STRING. The data are presented as means (±SD, n = 3-5). One-way ANOVA was used to show significance and was illustrated as follows: **** p < 0.0001.
Extracellular Loop, supplied by Sino Biological, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/extracellular loop/product/Sino Biological
Average 94 stars, based on 1 article reviews
extracellular loop - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier
monoclonal mouse antibody against tetraspanin cd81  (Proteintech)
96
Proteintech monoclonal mouse antibody against tetraspanin cd81
Lentiviral transduction to generate WT-, PanKO-, CD9KO-, CD63KO-, and CD81KO-cells expressing TlucCD9-Cerulean. A. Schematic workflow of generating engineered Tluc-EVs by introducing TlucCD9-Cerulean lentiviruses (created with BioRender.com ). B. The percentage of Cerulean positive cells. C. The mean fluorescence intensity (MFI) of Cerulean positive cells. D. Flow cytometry plot for the cells after staining with APC-conjugated <t>CD9/CD63/CD81</t> tetraspanin antibodies. E. Fold increase in engineered Tluc-CD9 EVs in PanKO-, CD9KO, CD63KO-, and CD81KO-cells over WT cells (Data are normalized to the RLU of EVs from WT cells). F. Fold increase of engineered Tluc-CD9EVs over PanKO-, CD9KO, CD63KO-, and CD81KO-cells (Data are normalized to the RLU of EVs from WT cells and compared across KO groups). G. Heatmap of tetraspanins in EVs. H. Interaction network of CD9 with the tetraspanins retrieved from STRING. The data are presented as means (±SD, n = 3-5). One-way ANOVA was used to show significance and was illustrated as follows: **** p < 0.0001.
Monoclonal Mouse Antibody Against Tetraspanin Cd81, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/monoclonal mouse antibody against tetraspanin cd81/product/Proteintech
Average 96 stars, based on 1 article reviews
monoclonal mouse antibody against tetraspanin cd81 - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier
tetraspanin proteins  (Miltenyi Biotec)
94
Miltenyi Biotec tetraspanin proteins
Lentiviral transduction to generate WT-, PanKO-, CD9KO-, CD63KO-, and CD81KO-cells expressing TlucCD9-Cerulean. A. Schematic workflow of generating engineered Tluc-EVs by introducing TlucCD9-Cerulean lentiviruses (created with BioRender.com ). B. The percentage of Cerulean positive cells. C. The mean fluorescence intensity (MFI) of Cerulean positive cells. D. Flow cytometry plot for the cells after staining with APC-conjugated <t>CD9/CD63/CD81</t> tetraspanin antibodies. E. Fold increase in engineered Tluc-CD9 EVs in PanKO-, CD9KO, CD63KO-, and CD81KO-cells over WT cells (Data are normalized to the RLU of EVs from WT cells). F. Fold increase of engineered Tluc-CD9EVs over PanKO-, CD9KO, CD63KO-, and CD81KO-cells (Data are normalized to the RLU of EVs from WT cells and compared across KO groups). G. Heatmap of tetraspanins in EVs. H. Interaction network of CD9 with the tetraspanins retrieved from STRING. The data are presented as means (±SD, n = 3-5). One-way ANOVA was used to show significance and was illustrated as follows: **** p < 0.0001.
Tetraspanin Proteins, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/tetraspanin proteins/product/Miltenyi Biotec
Average 94 stars, based on 1 article reviews
tetraspanin proteins - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier
exoview tetraspanin chips  (NanoView Biosciences)
90
NanoView Biosciences exoview tetraspanin chips
Lentiviral transduction to generate WT-, PanKO-, CD9KO-, CD63KO-, and CD81KO-cells expressing TlucCD9-Cerulean. A. Schematic workflow of generating engineered Tluc-EVs by introducing TlucCD9-Cerulean lentiviruses (created with BioRender.com ). B. The percentage of Cerulean positive cells. C. The mean fluorescence intensity (MFI) of Cerulean positive cells. D. Flow cytometry plot for the cells after staining with APC-conjugated <t>CD9/CD63/CD81</t> tetraspanin antibodies. E. Fold increase in engineered Tluc-CD9 EVs in PanKO-, CD9KO, CD63KO-, and CD81KO-cells over WT cells (Data are normalized to the RLU of EVs from WT cells). F. Fold increase of engineered Tluc-CD9EVs over PanKO-, CD9KO, CD63KO-, and CD81KO-cells (Data are normalized to the RLU of EVs from WT cells and compared across KO groups). G. Heatmap of tetraspanins in EVs. H. Interaction network of CD9 with the tetraspanins retrieved from STRING. The data are presented as means (±SD, n = 3-5). One-way ANOVA was used to show significance and was illustrated as follows: **** p < 0.0001.
Exoview Tetraspanin Chips, supplied by NanoView Biosciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/exoview tetraspanin chips/product/NanoView Biosciences
Average 90 stars, based on 1 article reviews
exoview tetraspanin chips - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
anti-human tetraspanin vtagtm antibody cocktail pe  (Cellarcus Biosciences Inc)
90
Cellarcus Biosciences Inc anti-human tetraspanin vtagtm antibody cocktail pe
Lentiviral transduction to generate WT-, PanKO-, CD9KO-, CD63KO-, and CD81KO-cells expressing TlucCD9-Cerulean. A. Schematic workflow of generating engineered Tluc-EVs by introducing TlucCD9-Cerulean lentiviruses (created with BioRender.com ). B. The percentage of Cerulean positive cells. C. The mean fluorescence intensity (MFI) of Cerulean positive cells. D. Flow cytometry plot for the cells after staining with APC-conjugated <t>CD9/CD63/CD81</t> tetraspanin antibodies. E. Fold increase in engineered Tluc-CD9 EVs in PanKO-, CD9KO, CD63KO-, and CD81KO-cells over WT cells (Data are normalized to the RLU of EVs from WT cells). F. Fold increase of engineered Tluc-CD9EVs over PanKO-, CD9KO, CD63KO-, and CD81KO-cells (Data are normalized to the RLU of EVs from WT cells and compared across KO groups). G. Heatmap of tetraspanins in EVs. H. Interaction network of CD9 with the tetraspanins retrieved from STRING. The data are presented as means (±SD, n = 3-5). One-way ANOVA was used to show significance and was illustrated as follows: **** p < 0.0001.
Anti Human Tetraspanin Vtagtm Antibody Cocktail Pe, supplied by Cellarcus Biosciences Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti-human tetraspanin vtagtm antibody cocktail pe/product/Cellarcus Biosciences Inc
Average 90 stars, based on 1 article reviews
anti-human tetraspanin vtagtm antibody cocktail pe - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


Lentiviral transduction to generate WT-, PanKO-, CD9KO-, CD63KO-, and CD81KO-cells expressing TlucCD9-Cerulean. A. Schematic workflow of generating engineered Tluc-EVs by introducing TlucCD9-Cerulean lentiviruses (created with BioRender.com ). B. The percentage of Cerulean positive cells. C. The mean fluorescence intensity (MFI) of Cerulean positive cells. D. Flow cytometry plot for the cells after staining with APC-conjugated CD9/CD63/CD81 tetraspanin antibodies. E. Fold increase in engineered Tluc-CD9 EVs in PanKO-, CD9KO, CD63KO-, and CD81KO-cells over WT cells (Data are normalized to the RLU of EVs from WT cells). F. Fold increase of engineered Tluc-CD9EVs over PanKO-, CD9KO, CD63KO-, and CD81KO-cells (Data are normalized to the RLU of EVs from WT cells and compared across KO groups). G. Heatmap of tetraspanins in EVs. H. Interaction network of CD9 with the tetraspanins retrieved from STRING. The data are presented as means (±SD, n = 3-5). One-way ANOVA was used to show significance and was illustrated as follows: **** p < 0.0001.

Journal: bioRxiv

Article Title: Evaluation of Tetraspanins in Extracellular Vesicle Bioengineering

doi: 10.64898/2026.01.13.699196

Figure Lengend Snippet: Lentiviral transduction to generate WT-, PanKO-, CD9KO-, CD63KO-, and CD81KO-cells expressing TlucCD9-Cerulean. A. Schematic workflow of generating engineered Tluc-EVs by introducing TlucCD9-Cerulean lentiviruses (created with BioRender.com ). B. The percentage of Cerulean positive cells. C. The mean fluorescence intensity (MFI) of Cerulean positive cells. D. Flow cytometry plot for the cells after staining with APC-conjugated CD9/CD63/CD81 tetraspanin antibodies. E. Fold increase in engineered Tluc-CD9 EVs in PanKO-, CD9KO, CD63KO-, and CD81KO-cells over WT cells (Data are normalized to the RLU of EVs from WT cells). F. Fold increase of engineered Tluc-CD9EVs over PanKO-, CD9KO, CD63KO-, and CD81KO-cells (Data are normalized to the RLU of EVs from WT cells and compared across KO groups). G. Heatmap of tetraspanins in EVs. H. Interaction network of CD9 with the tetraspanins retrieved from STRING. The data are presented as means (±SD, n = 3-5). One-way ANOVA was used to show significance and was illustrated as follows: **** p < 0.0001.

Article Snippet: Briefly, 2.5 × 10 8 EVs, quantified by NTA, were stained with 8 nM fluorescent antibodies targeting the tetraspanins CD9-APC (clone: SN4 C3-3A2, cat. 130-128-037), CD63-APC (clone: H5C6, cat. 130-100-182, Miltenyi Biotec), and CD81-APC (clone: JS64, Beckman Coulter).

Techniques: Transduction, Expressing, Fluorescence, Flow Cytometry, Staining

Lentiviral transduction to generate WT, PanKO, CD9KO, CD63KO, and CD81KO cells expressing TlucCD63-Cerulean. A. Schematic workflow of engineered Tluc-EVs by introducing TlucCD63-Cerulean lentiviruses (created with BioRender.com ). B. The percentage of Cerulean positive cells. C. The mean fluorescent intensity (MFI) of Cerulean positive cells. D. Flow cytometry plot for the cells after staining with APC-conjugated CD9/CD63/CD81 tetraspanin antibodies. E. Fold increase of engineered Tluc-CD63 EVs in PanKO-, CD9KO, CD63KO-, and CD81KO-cells over WT cells (Data are normalized to the RLU of EVs from WT cells). F. Fold increase of engineered Tluc-CD63EVs in between PanKO-, CD9KO, CD63KO-, and CD81KO-cells (Data are normalized to the RLU of EVs from WT cells and compared across KO groups). G. Heatmap of expressing tetraspanins in EVs. H. Interaction network of CD63 with the tetraspanins retrieved from STRING. The data are presented as means (±SD, n = 3-5). One-way ANOVA was used to show significance and was illustrated as follows: * p < 0.05, ** p < 0.01, **** p < 0.0001.

Journal: bioRxiv

Article Title: Evaluation of Tetraspanins in Extracellular Vesicle Bioengineering

doi: 10.64898/2026.01.13.699196

Figure Lengend Snippet: Lentiviral transduction to generate WT, PanKO, CD9KO, CD63KO, and CD81KO cells expressing TlucCD63-Cerulean. A. Schematic workflow of engineered Tluc-EVs by introducing TlucCD63-Cerulean lentiviruses (created with BioRender.com ). B. The percentage of Cerulean positive cells. C. The mean fluorescent intensity (MFI) of Cerulean positive cells. D. Flow cytometry plot for the cells after staining with APC-conjugated CD9/CD63/CD81 tetraspanin antibodies. E. Fold increase of engineered Tluc-CD63 EVs in PanKO-, CD9KO, CD63KO-, and CD81KO-cells over WT cells (Data are normalized to the RLU of EVs from WT cells). F. Fold increase of engineered Tluc-CD63EVs in between PanKO-, CD9KO, CD63KO-, and CD81KO-cells (Data are normalized to the RLU of EVs from WT cells and compared across KO groups). G. Heatmap of expressing tetraspanins in EVs. H. Interaction network of CD63 with the tetraspanins retrieved from STRING. The data are presented as means (±SD, n = 3-5). One-way ANOVA was used to show significance and was illustrated as follows: * p < 0.05, ** p < 0.01, **** p < 0.0001.

Article Snippet: Briefly, 2.5 × 10 8 EVs, quantified by NTA, were stained with 8 nM fluorescent antibodies targeting the tetraspanins CD9-APC (clone: SN4 C3-3A2, cat. 130-128-037), CD63-APC (clone: H5C6, cat. 130-100-182, Miltenyi Biotec), and CD81-APC (clone: JS64, Beckman Coulter).

Techniques: Transduction, Expressing, Flow Cytometry, Staining

Lentiviral transduction to generate WT-, PanKO-, CD9KO-, CD63KO-, and CD81KO-cells expressing TlucCD9-Cerulean. A. Schematic workflow of engineered Tluc-EVs by introducing TlucCD81-Cerulean lentiviruses (created with BioRender.com ). B. The percentage of Cerulean positive cells. C. The MFI of Cerulean positive cells. D. Flow cytometry plot for the cells after staining with APC-conjugated CD9/CD63/CD81 tetraspanin antibodies. E. Fold increase of engineered Tluc-CD81 EVs in PanKO-, CD9KO, CD63KO-, and CD81KO-cells over WT cells (Data are normalized to the RLU of EVs from WT cells). F. Fold increase of engineered Tluc-CD81EVs in between PanKO-, CD9KO, CD63KO-, and CD81KO-cells (Data are normalized to the RLU of EVs from WT cells and compared across KO groups). G. Heatmap of expressing tetraspanins in EVs. H. Interaction network of CD81 with the tetraspanins retrieved from STRING. The data are presented as means (±SD, n = 3-5). One-way ANOVA was used to show significance and was illustrated as follows: ** p < 0.01,** * p < 0.001,**** p < 0.0001.

Journal: bioRxiv

Article Title: Evaluation of Tetraspanins in Extracellular Vesicle Bioengineering

doi: 10.64898/2026.01.13.699196

Figure Lengend Snippet: Lentiviral transduction to generate WT-, PanKO-, CD9KO-, CD63KO-, and CD81KO-cells expressing TlucCD9-Cerulean. A. Schematic workflow of engineered Tluc-EVs by introducing TlucCD81-Cerulean lentiviruses (created with BioRender.com ). B. The percentage of Cerulean positive cells. C. The MFI of Cerulean positive cells. D. Flow cytometry plot for the cells after staining with APC-conjugated CD9/CD63/CD81 tetraspanin antibodies. E. Fold increase of engineered Tluc-CD81 EVs in PanKO-, CD9KO, CD63KO-, and CD81KO-cells over WT cells (Data are normalized to the RLU of EVs from WT cells). F. Fold increase of engineered Tluc-CD81EVs in between PanKO-, CD9KO, CD63KO-, and CD81KO-cells (Data are normalized to the RLU of EVs from WT cells and compared across KO groups). G. Heatmap of expressing tetraspanins in EVs. H. Interaction network of CD81 with the tetraspanins retrieved from STRING. The data are presented as means (±SD, n = 3-5). One-way ANOVA was used to show significance and was illustrated as follows: ** p < 0.01,** * p < 0.001,**** p < 0.0001.

Article Snippet: Briefly, 2.5 × 10 8 EVs, quantified by NTA, were stained with 8 nM fluorescent antibodies targeting the tetraspanins CD9-APC (clone: SN4 C3-3A2, cat. 130-128-037), CD63-APC (clone: H5C6, cat. 130-100-182, Miltenyi Biotec), and CD81-APC (clone: JS64, Beckman Coulter).

Techniques: Transduction, Expressing, Flow Cytometry, Staining

Generation of CD63-mNG-EVs in WT, PanKO-, CD9KO-, CD63KO-, and CD81KO-cells. A. Schematic workflow of engineered mNG-EVs by introducing CD63-mNG lentiviruses “created with BioRender.com ”. B. Percentage of mNG positive cells after transduction using flow cytometry. C. MFI of the cells using flow cytometry. D. The flow cytometry plot for the cells after transduction, stained with APC-conjugated CD9/CD63/CD81 tetraspanin antibodies. E. Quantification of engineered CD63-mNG EVs from 17 µL of CM collected from KO) and WT cells. F. Imaging flow cytometry plot for the mNG-EVs derived from stably expressing mNG cells. The data are presented as means (±SD, n = 2-3). One-way ANOVA was used to show significance and was illustrated as follows: * p< 0.05; ** p < 0.01; *** p < 0.001.

Journal: bioRxiv

Article Title: Evaluation of Tetraspanins in Extracellular Vesicle Bioengineering

doi: 10.64898/2026.01.13.699196

Figure Lengend Snippet: Generation of CD63-mNG-EVs in WT, PanKO-, CD9KO-, CD63KO-, and CD81KO-cells. A. Schematic workflow of engineered mNG-EVs by introducing CD63-mNG lentiviruses “created with BioRender.com ”. B. Percentage of mNG positive cells after transduction using flow cytometry. C. MFI of the cells using flow cytometry. D. The flow cytometry plot for the cells after transduction, stained with APC-conjugated CD9/CD63/CD81 tetraspanin antibodies. E. Quantification of engineered CD63-mNG EVs from 17 µL of CM collected from KO) and WT cells. F. Imaging flow cytometry plot for the mNG-EVs derived from stably expressing mNG cells. The data are presented as means (±SD, n = 2-3). One-way ANOVA was used to show significance and was illustrated as follows: * p< 0.05; ** p < 0.01; *** p < 0.001.

Article Snippet: Briefly, 2.5 × 10 8 EVs, quantified by NTA, were stained with 8 nM fluorescent antibodies targeting the tetraspanins CD9-APC (clone: SN4 C3-3A2, cat. 130-128-037), CD63-APC (clone: H5C6, cat. 130-100-182, Miltenyi Biotec), and CD81-APC (clone: JS64, Beckman Coulter).

Techniques: Transduction, Flow Cytometry, Staining, Imaging, Derivative Assay, Stable Transfection, Expressing